Mechanistic characterisation of enhancer hijacking: identifying essential and targetable chromatin interactions

增强子劫持的机制表征:识别必要的和可靶向的染色质相互作用

基本信息

  • 批准号:
    MR/Y011902/1
  • 负责人:
  • 金额:
    $ 107.03万
  • 依托单位:
  • 依托单位国家:
    英国
  • 项目类别:
    Research Grant
  • 财政年份:
    2024
  • 资助国家:
    英国
  • 起止时间:
    2024 至 无数据
  • 项目状态:
    未结题

项目摘要

Our genetic code is like a recipe book: we need instructions and ingredients to produce the cells within our body. The ingredients are called genes, and in healthy cells, enhancers provide the instructions that say which genes are to be switched on and when. In patients with blood cancers, some enhancers get moved to new locations within the genetic code, and because of this they end up switching on the wrong gene. This is known as 'enhancer hijacking' and has been shown to contribute to the development of cancer. To understand how enhancers instruct the wrong genes we need to learn about the communication between enhancers and genes in both healthy and cancer cells. We also need to shut down these enhancers to prevent communication and record the response of the cells. By stopping enhancers communicating with the wrong genes, we hope to kill the cancer cells.We can edit the genomes of cancer cells in the laboratory, making alterations to regions within enhancers to shut them down. This can help us understand how enhancer hijacking works, and develop new treatments to reverse the effects of the hijacking (i.e., to stop the wrong genes from being switched on). However, identifying the most important parts of the enhancers is difficult, and the laboratory experiments are time consuming and expensive. In this project, we will develop and test a new computer programme which can identify these important sites, and predict the effects of the genome editing experiments. It will be possible to quickly mimic an experiment using the computer programme, trying many different scenarios before going into the lab. This will accelerate and improve the targeting of the experiments, saving time and money, and revolutionise the way we design our experiments. As well as this, the computer models will provide new insight and understanding of how enhancers switch on the wrong genes to cause disease, and how genes and enhancers communicate more generally. This work is important because the changes to the genetic code that we are interested in are found in patients who do not respond well to current treatments. By understanding how enhancers communicate with genes, we can look to block this interaction. In the longer term, this will enable us to develop more specific treatments that only target the cancer cells, reducing side-effects of treatment and improving the lives of those living with cancer.Our team brings together researchers with very different skill sets - laboratory-based cancer biology and computational biophysics. Having both of these aspects will be crucial for taking this exciting work forward. We have successfully worked together for over three years and have already published new findings for the scientific community. The experimental protocols that we will use are already established within the group and the computer model that we plan to build on has already proved successful in multiple projects. By continuing this successful collaboration, together with our project partners, we hope to make significant contributions to knowledge about how hijacked enhancers communicate with genes. If successful this approach could be applied to many different cancers which involve enhancer hijacking.
我们的遗传密码就像一本食谱:我们需要指令和成分来生产我们体内的细胞。这些成分被称为基因,在健康的细胞中,增强子提供指示,说明哪些基因将被打开以及何时打开。在血癌患者中,一些增强子被转移到遗传密码中的新位置,因此它们最终会打开错误的基因。这被称为“增强子劫持”,并已被证明有助于癌症的发展。为了理解增强子如何指导错误的基因,我们需要了解健康细胞和癌细胞中增强子和基因之间的通信。我们还需要关闭这些增强子,以阻止通信并记录细胞的反应。通过阻止增强子与错误基因的通讯,我们希望杀死癌细胞。我们可以在实验室里编辑癌细胞的基因组,改变增强子内的区域来关闭它们。这可以帮助我们了解增强子劫持是如何工作的,并开发新的治疗方法来逆转劫持的影响(即,以阻止错误的基因被打开)。然而,识别增强子的最重要部分是困难的,并且实验室实验耗时且昂贵。在这个项目中,我们将开发和测试一个新的计算机程序,它可以识别这些重要的位点,并预测基因组编辑实验的影响。使用计算机程序可以快速模拟实验,在进入实验室之前尝试许多不同的场景。这将加速和改善实验的目标,节省时间和金钱,并彻底改变我们设计实验的方式。除此之外,计算机模型还将提供新的见解和理解,即增强子如何打开错误的基因以引起疾病,以及基因和增强子如何更普遍地交流。这项工作很重要,因为我们感兴趣的遗传密码的变化是在对当前治疗反应不佳的患者中发现的。通过了解增强子如何与基因交流,我们可以阻止这种相互作用。从长远来看,这将使我们能够开发出只针对癌细胞的更具体的治疗方法,减少治疗的副作用,改善癌症患者的生活。我们的团队汇集了具有非常不同技能的研究人员-基于实验室的癌症生物学和计算生物物理学。拥有这两个方面对于推进这项令人兴奋的工作至关重要。我们已经成功地合作了三年多,并已经为科学界发表了新的发现。我们将使用的实验协议已经在小组内建立,我们计划建立的计算机模型已经在多个项目中证明是成功的。通过继续这种成功的合作,与我们的项目合作伙伴一起,我们希望对被劫持的增强子如何与基因交流的知识做出重大贡献。如果成功的话,这种方法可以应用于许多不同的涉及增强子劫持的癌症。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lisa Russell其他文献

Myocardial Perfusion SPECT/CT Image Optimisation for Patients of Varying BMI
  • DOI:
    10.1016/j.ejmp.2013.05.025
  • 发表时间:
    2013-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lisa Russell;Seán Cournane;Ann Larkin
  • 通讯作者:
    Ann Larkin
Transcription factor Ets-1 in cytokine and chemokine gene regulation
  • DOI:
    10.1016/j.cyto.2010.03.006
  • 发表时间:
    2010-09-01
  • 期刊:
  • 影响因子:
  • 作者:
    Lisa Russell;Lee Ann Garrett-Sinha
  • 通讯作者:
    Lee Ann Garrett-Sinha
Anguish and anxiety, stress and strain: Attending to writers’ stress in the dissertation process
痛苦和焦虑、压力和紧张:关注作者在论文过程中的压力
  • DOI:
    10.1016/j.jslw.2017.11.005
  • 发表时间:
    2017
  • 期刊:
  • 影响因子:
    6.1
  • 作者:
    Lisa Russell;M. L. Harris
  • 通讯作者:
    M. L. Harris
Understanding Text about Alzheimer’s Dementia
理解有关阿尔茨海默氏症的文本
  • DOI:
    10.1057/9780230502024_12
  • 发表时间:
    2005
  • 期刊:
  • 影响因子:
    2.2
  • 作者:
    Lisa Russell;Linda Moore
  • 通讯作者:
    Linda Moore

Lisa Russell的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

A Pathway to the Confirmation and Characterisation of Habitable Alien Worlds
确认和描述宜居外星世界的途径
  • 批准号:
    MR/Y011759/1
  • 财政年份:
    2025
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Fellowship
Integrated Tip-Enabled Nanofabrication and Characterisation at Atomic Scale
集成尖端纳米加工和原子级表征
  • 批准号:
    LE240100015
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
EMNANDI: Advanced Characterisation and Aging of Compostable Bioplastics for Automotive Applications
EMNANDI:汽车应用可堆肥生物塑料的高级表征和老化
  • 批准号:
    10089306
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Collaborative R&D
Molecular characterisation of pore-forming proteins as pest control agents
作为害虫防治剂的成孔蛋白的分子表征
  • 批准号:
    DE240100885
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Discovery Early Career Researcher Award
Ultra-fast structure-property characterisation of materials
材料的超快速结构-性能表征
  • 批准号:
    LE240100036
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Linkage Infrastructure, Equipment and Facilities
Characterisation of a novel disease immunity pathway in plants
植物新型疾病免疫途径的表征
  • 批准号:
    DP240102982
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Discovery Projects
Structural Characterisation of Bacteriophage Proteins Involved in Host Hijacking of Enterococcus Species
参与肠球菌宿主劫持的噬菌体蛋白的结构表征
  • 批准号:
    BB/Z515188/1
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Fellowship
NanoRAM: Emerging Nanotools for Soft Matter Characterisation and Manipulation
NanoRAM:用于软物质表征和操纵的新兴纳米工具
  • 批准号:
    EP/Y032306/1
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Research Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
  • 批准号:
    MR/Y008693/1
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Research Grant
In vitro safety and immunogenicity characterisation of SimCell vaccines
SimCell 疫苗的体外安全性和免疫原性表征
  • 批准号:
    10090244
  • 财政年份:
    2024
  • 资助金额:
    $ 107.03万
  • 项目类别:
    Collaborative R&D
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了